Association of PTPN22 C1858T and CTLA-4 A49G polymorphisms with type 1 diabetes in Croatians

Diabetes Research and Clinical Practice

Volumn 86, Issue 3, 2009, Pages

  Korolija, Marina ^a   Renar, Ivana Pavlić ^b,c   Hadžija, Mirko ^a   Medvidović, Edita Pape ^c   Pavković, Pajica ^c   Jokić, Mladen ^a   Hadžija, Marijana Popović ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b KBC Zagreb   (Croatia)

^c University of Zagreb   (Croatia)

Author keywords

CTLA 4; Polymorphism; PTPN22; Type 1 diabetes

Indexed keywords

ALANINE; CYSTEINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLYCINE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; THREONINE;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROATIA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENINE; ADULT; AGE OF ONSET; ANTIGENS, CD; BLOOD GLUCOSE; CROATIA; CYTOSINE; DIABETES MELLITUS, TYPE 1; DNA PRIMERS; GENETIC VARIATION; GENOTYPE; GUANINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; RISK ASSESSMENT; THYMINE;

EID: 70350620434     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.09.012     Document Type: Article

References (17)

1. Bottini N., Vang T., Cucca F., and Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune disease. Semin. Immunol. 18 (2006) 207-213
2. Fife B.T., and Bluestone J.A. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol. Rev. 224 (2008) 166-182
3. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., et al. A functional variant of lymphoid tyrosine phosphates is associated with type 1 diabetes. Nat. Genet. 36 (2004) 337-338
4. Zheng W., and She J.X. Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes. Diabetes 54 (2005) 906-908
5. Smyth D., Cooper J.D., Collins J.E., Heward J.M., Franklyn J.A., Howson J.M.M., et al. Replication of an association between the lymphoid tyrosine phosphates locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53 (2004) 3020-3023
6. Baniasadi V., Narain N., Goswami R., and Das S.N. Promoter region-318C/T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians. Tissue Antigens 67 (2006) 383-389
7. Mojtahedi Z., Omrani G.R., Doroudchi M., and Ghaderi A. CTLA-4+49 A/G polymorphism is associated with predisposition to type 1 diabetes in Iranians. Diab. Res. Clin. Pract. 68 (2005) 111-116
8. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 (1988) 1215
9. Hermann R., Lipponen K., Kiviniemi M., Kakko T., Veijola R., Simell O., et al. Lymphoid tyrosine phosphates (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes. Diabetologia 49 (2006) 1198-1208
10. Kahles H., Ramos-Lopez E., Lange B., Zwermann O., Reincke M., and Badenhoop K. Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. Eur. J. Endocrinol. 153 (2005) 895-899
11. Nielsen C., Hansen D., Husby S., and Lillevang S.T. Sex-specific association of the human PTPN22 1858T-allele with type 1 diabetes. Int. J. Immunogenet. 34 (2007) 469-473
12. Douroudis K., Prans E., Haller K., Nemvalts V., Rajasalu T., Tillmann V., et al. Protein tyrosine phospatase non-receptor type 22 gene variants at position 1858 are associated with type 1 and type 2 diabetes in Estonian population. Tissue Antigens 72 (2008) 425-430
13. Ide A., Kawasaki E., Abiru N., Fuyan S., Kobayashi M., Fukushima T., et al. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J. Autoimmun. 22 (2004) 73-78
14. Haller K., Kisand K., Pisarev H., Salur L., Laisk T., Nemvalts V., et al. Insulin gene VNTR, CTLA-4+49A/G and HLA-DQB1 alleles distinguish latent autoimmune diabetes in adults from type 1 diabetes and from type 2 diabetes group. Tissue Antigens 69 (2007) 121-127
15. Kavvoura K.F., and Ioannidis P.A. CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a huge review and meta-analysis. Am. J. Epidemiol. 162 (2005) 3-16
16. Genc S., Genc K., Sercan O., Kizildag S., Gulay Z., Atay T., et al. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) exon 1 polymorphisms in patients with type 1 diabetes mellitus in a Turkish population. J. Pediatr. Endocr. Met. 17 (2004) 731-735
17. Caillant-Zucman S., Garchon H.J., Timsit J., Assan C., Boitard I., Dijalah-Saiah P., et al. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J. Clin. Invest. 90 (1992) 2242-2250